Risk Factors for Liver Function Deterioration after Transarterial Chemoembolization Refractoriness in Child-Pugh Class A Hepatocellular Carcinoma Patients

Background/Aims: A switch to systemic therapy, such as sorafenib, should be considered for hepatocellular carcinoma (HCC) patients refractory to transarterial chemoembolization (TACE). On the other hand, treatment changes are difficult if the liver function worsens to Child-Pugh B or C. Therefore, p...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kang Hyun Park, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Byung Chul Yoo, Jin Ho Hwang, Sang Woo Park, Young Jun Kim, Hee Sun Park, Mi Hye Yu, Hae Jeong Jeon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Jin Publishing & Printing Co. 2020-03-01
Sarja:The Korean Journal of Gastroenterology
Aiheet:
carcinoma
hepatocellular
chemoembolization
therapeutic
Linkit:http://www.kjg.or.kr/journal/view.html?uid=5557&vmd=Full&
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia